Advancing Cardiovascular Care 2026: Emerging Therapies and Strategies

This comprehensive continuing medical educational program is designed to equip physicians with the latest knowledge and tools for diagnosing and managing complex cardiovascular conditions. Through a focus on emerging therapies, innovative technologies, and evidence-based strategies, participants will gain practical insights to optimize patient outcomes in a variety of challenging clinical scenarios. Topics will include advancements in heart failure management, mechanical circulatory support, arrhythmia therapies, pulmonary hypertension, cardiogenic shock, and more. Upon completion of this course, participants will be better prepared to integrate cutting-edge therapies and technologies into their practice, improve diagnostic accuracy, and enhance patient-centered care for individuals with cardiovascular diseases.

1. Analyze the latest evidence and clinical trial data to inform the management of heart failure, pulmonary hypertension, and cardiogenic shock.
2. Identify appropriate patient populations for innovative treatments and integrate them into personalized, multidisciplinary care plans.
3. Evaluate the role of emerging therapies and technologies, including renal artery denervation, Barostim, CCM, and M-TEER, in treating cardiovascular diseases.
4. Develop systematic approaches to diagnosing complex cardiovascular conditions, including amyloidosis, hypertrophic cardiomyopathy (HCM), and cardiorenal syndrome.
5. Optimize the use of advanced mechanical circulatory support devices like VA ECMO, Impella, and subcutaneous ICDs.
6. Improve their understanding of the pathophysiology, clinical manifestations, and management strategies for conditions such as atrial fibrillation, ventricular tachycardia, and shock.

*Must use a valid Scripps email address when registering.

**To receive the student, resident, fellow registration discount code, please email or call Scripps CME and provide proof of your status.

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Scripps Health designates this activity for a maximum of 11.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

American Board of Internal Medicine
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Attendee Cancellation, Substitution and Refund
The course tuition is refundable, minus a $100 processing fee (MD, DO, RN, PA, NP) or a $50 processing fee (Students, Residents, Fellows), if your cancellation is received in writing no later than Friday, April 24, 2026. Attendee substitutions are allowed, but notification must be made in writing by Friday, April 24, 2026. After this date, under no circumstances will refunds, credits, or substitutions be granted. No refunds or credits will be given to “no shows.” No refunds shall be made for cancellations due to inclement weather.

Scripps Course Modification or Cancellation
Scripps reserves the right to modify the course’s schedule or program as necessary. Scripps also reserves the right to cancel this course, in which case a full refund of the registration fee will be provided. Attendees who purchase non-refundable airline tickets do so at their own risk. Scripps encourages the purchase of travel insurance as we are unable to refund any travel costs (flight, hotel, etc.) in the case of Scripps cancellation.

Recording and Photography Clause
Scripps reserves exclusive rights to record (audio and video) and/or photograph all course proceedings for use in marketing materials, presentations and course content sales.

Family and Guest Attendance Policy
All course activities and meals are exclusively reserved for paid course attendees. Children and family members are not allowed to attend meal functions or permitted in the meeting space.

Accessibility Statement
Scripps is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodation, including dietary concerns, please email [email protected].

The Westin San Diego Gaslamp Quarter
910 Broadway Cir
San Diego, California 92101
Reservations: 619-239-2200
Reserve a Discounted Room

Please make your own hotel reservations and request the Scripps course reduced rate of $279 per night (plus tax and parking). Make your reservations early! A block of rooms is being held for us at the special rate of $279 per night until Thursday, April 16, 2026, or until the room block fills, whichever comes first. After this date, reservations will be accepted on a space and rate availability basis only. Attendees who book their room through an online, third-party service are not eligible for room block concessions including waived resort fee.

Important Note
We have been made aware that participants are receiving emails from organizations posing as third-party booking sites, encouraging them to reserve rooms for the course through their service or link. Please be advised that these emails are phishing schemes, and the organizations involved are not affiliated with Scripps or the course hotel in any way.

Mitigation of Relevant Financial Relationships

Disclosure of Relevant Financial Relationships and Content Validity

It is policy at Scripps Health’s Office of Continuing Medical Education (CME) for course directors, planners, moderators, faculty, and all others in a position to control content of an educational activity disclose all financial relationships with ineligible companies that they may have had within the past 24 months. This policy is in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. If an individual refuses to disclose financial relationships, they will be disqualified from being a part of the planning and implementation of the activity. Owners and/or employees of an ineligible company with business lines or products relating to the content of the activity will not be permitted to participate in the planning or execution of any accredited program.

The intent of this policy is to ensure that Scripps Health CME/CE certified activities promote quality and safety, are effective in improving medical practice, consist of valid, evidence-based content, and are independent of control from ineligible companies and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain any financial relationships. This process consisted of reviewing the content, determining which financial relationships were relevant, and applying appropriate mitigation strategies. All listed relevant financial relationships with ineligible companies for individuals in control of content have been mitigated prior to the commencement of the activity.

The staff in Scripps Health’s Office of Continuing Medical Education have disclosed that they have no financial relationships with any ineligible companies. Any peer reviewer who is determined to have a relevant financial relationship must recuse themselves from the peer review process.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Carlin Admirand, BS
Scripps Health
San Diego, CA

Activity Administrator

Nothing to disclose

Gabriel Flores
Scripps Health
San Diego, CA

Activity Coordinator

Nothing to disclose

Rola Khedraki, MD, FACC
Scripps Clinic
La Jolla, CA

Co-Director, Faculty

Speakers Bureau-AstraZeneca (Any division)|Speakers Bureau-Alnylam|Consulting Fee-Alnylam|Consulting Fee-BridgeBio|Consulting Fee-Pfizer (Any division)|Consulting Fee-Kestra Medical

Rajeev C Mohan, MD
Scripps Clinic
La Jolla, CA

Co-Director, Faculty

Consulting Fee-AstraZeneca (Any division)|Consulting Fee-Pfizer (Any division)|Consulting Fee-Alnylam|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-CVRx|Consulting Fee-Alleviant Medical|Consulting Fee-Corvia Medical|Consulting Fee-BridgeBio|Consulting Fee-Bayer (Any division)|Grant or research support-Alleviant Medical|Grant or research support-Corvia Medical|Consulting Fee-InterShunt

Laith Alshawabkeh, MD
UCSD School of Medicine
La Jolla, CA

Faculty

Mir Babar Basir, DO, FACC, FSCAI
Henry Ford Hospitals
Detroit, MI

Faculty

Andrew J Cheng, MD
Scripps Clinic
La Jolla, CA

Faculty

Shawn Evans, MD
Scripps Memorial Hospital La Jolla
San Diego, CA

Faculty

Douglas N Gibson, MD
Scripps Clinic
La Jolla, CA

Faculty

James T Heywood, MD, FACC
Scripps Clinic
La Jolla, CA

Faculty

Andrew Higgins, MD, FACC, FCCP
Cleveland Clinic
Cleveland, OH

Faculty

Andrew J King, MD
Scripps Clinic
La Jolla, CA

Faculty

Nicholas Olson, MD
Scripps Clinic
La Jolla, CA

Faculty

Demosthenes G Papamatheakis, MD
UCSD School of Medicine
La Jolla, CA

Faculty

Matthew J Price, MD, FACC, FSCAI
Scripps Clinic
La Jolla, CA

Faculty

Consulting Fee-Abbott (Any division)|Consulting Fee-Alleviant Medical|Consulting Fee-Axio Research|Consulting Fee-Boston Scientific Corporation|Consulting Fee-W. L. Gore & Associates, Inc.|Consulting Fee-InnovHeart|Consulting Fee-Johnson & Johnson|Consulting Fee-Medtronic (Any division)|Consulting Fee-Philips (Any division)|Consulting Fee-Shockwave Medical|Other: Equity-Atraverse|Other: Equity-Bolt Medical|Other: Equity-Indian Wells Medical|Other: Equity-InterShunt

Austin Robinson, MD
Scripps Clinic
La Jolla, CA

Faculty

John D Rogers, MD, FACC, FHRS
Scripps Clinic
La Jolla, CA

Faculty

Speakers Bureau-Medtronic (Any division)|Consulting Fee-Boston Scientific Corporation|Speakers Bureau-Kestra Medical|Speakers Bureau-Philips (Any division) (Relationship has ended)

Pratyaksh Srivastava, MD, FACC
San Diego Cardiac Center
San Diego, CA

Faculty

Speakers Bureau-Bayer (Any division)|Speakers Bureau-BridgeBio

Curtiss T Stinis, MD, FACC, FSCAI
Scripps Clinic
La Jolla, CA

Faculty

Consulting Fee-Edwards Lifesciences Corporation|Consulting Fee-Medtronic (Any division)|Speakers Bureau-Shockwave Medical|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Boston Scientific Corporation

Nadeem Tabbara, MD
UCSD School of Medicine
La Jolla, CA

Faculty

Paul S Teirstein, MD, FACC, FSCAI
Scripps Clinic
La Jolla, CA

Faculty

Consulting Fee-Abbott (Any division)|Consulting Fee-Shockwave|Consulting Fee-Boston Scientific Corporation|Consulting Fee-Medtronic (Any division)|Consulting Fee-AbioMed|Grant or research support-Abbott (Any division)|Grant or research support-Boston Scientific Corporation|Grant or research support-Edwards Lifesciences Corporation|Grant or research support-Medtronic (Any division)|Other: Equity-SoloPace

Howie Tran, MD, FACC, FHFSA
UCSD School of Medicine
La Jolla, CA

Faculty

Marcus Urey, MD
UCSD School of Medicine
La Jolla, CA

Faculty

Please download and review the support prospectus for details on what is and what is not included with the various support options:

Advancing Cardiovascular Care 2026: Emerging Therapies and Strategies Exhibit and Support Prospectus